Literature DB >> 35241525

Down-regulation of AMPD3 Is Associated With Poor Survival in Head and Neck Squamous Cell Carcinoma.

Cheng-Ming Hsu1,2, Shun-Fu Chang3, Yao-Te Tsai1, Ming-Shao Tsai1, Geng-He Chang1, Hung-Chin Chen1, Ping-Chung Huang1, Chien-An Ko1, Chin-Yuan Wu4, Sheng-Fung Lin5, Ming-Yu Yang6,7.   

Abstract

BACKGROUND: Adenosine monophosphate deaminase 3 (AMPD3) is an isoenzyme involved in the regulation of the energetic metabolism of mammalian cells. Cancer cells have a high demand for their energy supply. This experimental study aimed to illustrate the role of AMPD3 in human head and neck squamous cell carcinoma (HNSCC).
MATERIALS AND METHODS: Real-time quantitative reverse transcription-polymerase chain reaction was used to investigate the expression of the AMPD3 gene in human HNSCC tissues to assess the changes in cancerous and noncancerous parts and the correlation with different tumor behavior. The functions of AMPD3 were investigated using wound-healing and migration assays.
RESULTS: AMPD3 was significantly down-regulated in cancerous tissues of HNSCC (p=0.001) and this was correlated with more advanced tumor and clinical stages. Patients with high expression had better 5-year survival. AMPD3 knock-down in SCC-4 and SCC-25 cells demonstrated reduction of proliferation but increased migration and invasion.
CONCLUSION: To our knowledge, this is the first report evidencing the expression pattern of AMPD3 in HNSCC and demonstrated that high AMPD3 expression might represent a good prognostic biomarker. AMPD3 may have an antiproliferative potential but its down-regulation may not contribute to reducing the migration and invasion of HNSCC cells. Copyright
© 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  AMP-deaminase 3; head and neck squamous cell carcinoma; migration assay; patient survival; real-time quantitative RT-PCR; transwell assay

Mesh:

Substances:

Year:  2022        PMID: 35241525      PMCID: PMC8931920          DOI: 10.21873/invivo.12756

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  21 in total

Review 1.  Head and neck cancer--Part 1: Epidemiology, presentation, and prevention.

Authors:  H Mehanna; V Paleri; C M L West; C Nutting
Journal:  BMJ       Date:  2010-09-20

2.  Tumor suppressor gene ING3 induces cardiomyocyte hypertrophy via inhibition of AMPK and activation of p38 MAPK signaling.

Authors:  Jiaojiao Wang; Zhiping Liu; Xiaojun Feng; Si Gao; Suowen Xu; Peiqing Liu
Journal:  Arch Biochem Biophys       Date:  2014-08-20       Impact factor: 4.013

Review 3.  Head and neck cancer-part 1: epidemiology, presentation, and preservation.

Authors:  H Mehanna; V Paleri; C M L West; C Nutting
Journal:  Clin Otolaryngol       Date:  2011-02       Impact factor: 2.597

4.  Molecular analysis of mouse Ampd3 gene encoding heart-type isoform of AMP deaminase.

Authors:  T Morisaki; K Sermsuvitayawong; X Wang; A Nagabukuro; Y Matsuda; N Ogasawara; I Mineo; H Morisaki; T Mukai
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

5.  Locally advanced squamous cell carcinoma of the head and neck: A systematic review and Bayesian network meta-analysis of the currently available treatment options.

Authors:  Oreste Iocca; Alessio Farcomeni; Arianna Di Rocco; Pasquale Di Maio; Paweł Golusinski; Simón Pardiñas López; Alfredo Savo; Raul Pellini; Giuseppe Spriano
Journal:  Oral Oncol       Date:  2018-03-27       Impact factor: 5.337

Review 6.  Epidemiology and Molecular Biology of Head and Neck Cancer.

Authors:  Adriana Jou; Jochen Hess
Journal:  Oncol Res Treat       Date:  2017-05-19       Impact factor: 2.825

7.  Calcium activates erythrocyte AMP deaminase [isoform E (AMPD3)] through a protein-protein interaction between calmodulin and the N-terminal domain of the AMPD3 polypeptide.

Authors:  Donna K Mahnke; Richard L Sabina
Journal:  Biochemistry       Date:  2005-04-12       Impact factor: 3.162

8.  AMPK activation by oncogenesis is required to maintain cancer cell proliferation in astrocytic tumors.

Authors:  Marcos Ríos; Marc Foretz; Benoit Viollet; Angel Prieto; Máximo Fraga; Jose A Costoya; Rosa Señarís
Journal:  Cancer Res       Date:  2013-01-31       Impact factor: 12.701

9.  Inhibition by fluoxetine of LH-stimulated cyclic AMP synthesis in tumor Leydig cells partly involves AMPK activation.

Authors:  Thi Mong Diep Nguyen; Danièle Klett; Laura Filliatreau; Yves Combarnous
Journal:  PLoS One       Date:  2019-06-04       Impact factor: 3.240

10.  Activation of AMPK by metformin promotes renal cancer cell proliferation under glucose deprivation through its interaction with PKM2.

Authors:  Meihan Liu; Zhuo Zhang; Hui Wang; Xiaoliang Chen; Chunxiang Jin
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.